Correlation Between Ryman Healthcare and Novo Integrated

Can any of the company-specific risk be diversified away by investing in both Ryman Healthcare and Novo Integrated at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Ryman Healthcare and Novo Integrated into the same portfolio, which is an essential part of the fundamental portfolio management process.

By analyzing existing cross correlation between Ryman Healthcare Limited and Novo Integrated Sciences, you can compare the effects of market volatilities on Ryman Healthcare and Novo Integrated and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Ryman Healthcare with a short position of Novo Integrated. Check out your portfolio center. Please also check ongoing floating volatility patterns of Ryman Healthcare and Novo Integrated.

Diversification Opportunities for Ryman Healthcare and Novo Integrated

0.36

Correlation Coefficient

Ryman Healthcare  Novo Integrated

Weak diversification

The 3 months correlation between Ryman and Novo is 0.36. Overlapping area represents the amount of risk that can be diversified away by holding Ryman Healthcare Limited and Novo Integrated Sciences in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Novo Integrated Sciences and Ryman Healthcare is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Ryman Healthcare Limited are associated (or correlated) with Novo Integrated. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Novo Integrated Sciences has no effect on the direction of Ryman Healthcare i.e., Ryman Healthcare and Novo Integrated go up and down completely randomly.

Pair Corralation between Ryman Healthcare and Novo Integrated

Assuming the 90 days horizon Ryman Healthcare Limited is expected to generate 0.1 times more return on investment than Novo Integrated. However, Ryman Healthcare Limited is 9.61 times less risky than Novo Integrated. It trades about -0.05 of its potential returns per unit of risk. Novo Integrated Sciences is currently generating about -0.12 per unit of risk. If you would invest  282.00  in Ryman Healthcare Limited on September 13, 2024 and sell it today you would lose (21.00) from holding Ryman Healthcare Limited or give up 7.45% of portfolio value over 90 days.

Time Period	3 Months [change]
Direction	Moves Together
Strength	Very Weak
Accuracy	68.75%
Values	Daily Returns

Ryman Healthcare Limited  vs.  Novo Integrated Sciences

Ryman Healthcare

Risk-Adjusted Performance

0 of 100

Very Weak

Over the last 90 days Ryman Healthcare Limited has generated negative risk-adjusted returns adding no value to investors with long positions. Despite latest fragile performance, the Stock's technical and fundamental indicators remain stable and the current disturbance on Wall Street may also be a sign of long-run gains for the company stockholders.

Novo Integrated Sciences

Risk-Adjusted Performance

0 of 100

Very Weak

Over the last 90 days Novo Integrated Sciences has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of abnormal performance in the last few months, the Stock's basic indicators remain comparatively stable which may send shares a bit higher in January 2025. The newest uproar may also be a sign of mid-term up-swing for the firm private investors.

Pair Trading with Ryman Healthcare and Novo Integrated

The main advantage of trading using opposite Ryman Healthcare and Novo Integrated positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Ryman Healthcare position performs unexpectedly, Novo Integrated can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Novo Integrated will offset losses from the drop in Novo Integrated's long position.

The idea behind Ryman Healthcare Limited and Novo Integrated Sciences pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.

Check out your portfolio center.

Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Global Correlations module to find global opportunities by holding instruments from different markets.